Germany Metered Dose Inhaler Market Share 2019 Growth Challenges, Opportunities and Future Trends 2025
Germany metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the metered dose inhaler market. Major factors that augment the growth of the metered dose inhaler market in the country include the significant prevalence of respiratory diseases such as asthma and COPD coupled with increasing geriatric population and growing focus towards the development of therapeutics to treat respiratory diseases.
To Request a Sample of our Report on Germany
Metered Dose Inhaler Market: https://www.omrglobal.com/request-sample/germany-metered-dose-inhaler-market
According to the International
Monetary Fund, in 2017, the population of the country was about 80 million and
the share of the geriatric population is around 21%. Major companies working in
the field of respiratory drug and device industry. Ingelheim based Boehringer
Ingelheim International GmbH collaborated with Weill Cornell Medicine in
February 2017. The collaboration aims to find new treatment approaches for
chronic pulmonary diseases. The three-year collaboration aimed to develop novel
treatments that could stop and decrease the progression of COPD.
Germany metered dose inhaler
market is segmented based on type, application, and end-user. Based on the
type, preventive, reliever, and long-acting bronchodilators inhalers are
analyzed. The preventive inhaler segment led the global metered dose inhaler
market in 2018. Preventive inhalers are most widely used in the treatment of
asthma in children and adults. These inhalers do not entail side effects for
long-term use, and exceptionally decreases the possibility of an asthma
exacerbation. The preventive inhalers further reduce the airways swelling and
hence, are recommended for regular use by the physician. Some of the preventive
inhalers available in the market include Budesonide and Fluticasone. Moreover,
based on the application, the market has been classified into asthma and COPD
diseases. In addition, based on the end-user, homecare and hospitals and
clinics have been analyzed.
(Get 15% Discount on
Buying this Report)
A
full Report of Germany Metered Dose Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/germany-metered-dose-inhaler-market
Germany Metered Dose
Inhaler Market Segmentation
By Type
·
Preventive Dry Powdered Inhaler
·
Reliever Dry Powdered Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp
·
Adherium Ltd.
·
AstraZeneca PLC
·
Bespak
·
Boehringer
Ingelheim International GmbH
·
Chiesi
Farmaceutici S.P.A.
·
GlaxoSmithKline
PLC
·
H&T
Presspart Manufacturing Ltd.
·
Koninklijke
Philips N.V.
·
Novartis AG
·
Omron Healthcare
Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Teicos Pharma
Ltd.
·
Teva
Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment